CBCL

(redirected from Cutaneous B-Cell Lymphoma)
AcronymDefinition
CBCLChild Behavior Checklist (psychology)
CBCLCutaneous B-Cell Lymphoma
CBCLCenter for Biological and Computational Learning (Massachusetts Institute of Technology)
CBCLCanadian Bonded Credits Limited (Toronto, Ontario)
CBCLCommon Business Communication Language (business technology)
CBCLCommercial Bank of Ceylon Ltd. (Sri Lanka)
References in periodicals archive ?
Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.
Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.
The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
More recognized is the relationship between gastric mucosa-associated lymphoid tissue (MALT) lymphomas, which are similar to primary cutaneous B-cell lymphomas in the skin, and Helicobacter pylori infections.
In this clinical report, we describe the successful treatment of nonepitheliotropic cutaneous B-cell lymphoma in an umbrella cockatoo.
reported finding hepatitis C virus RNA sequences by reverse-transcriptase PCR in 7 of 23 tumor biopsies of various clinicopathologic subforms of cutaneous B-cell lymphoma.
burgdorferi might be a causative agent in some cutaneous B-cell lymphomas first emerged in the late 1990s with a European report that 9 of 50 consecutively studied archival tissue specimens of confirmed cutaneous B-cell lymphomas contained specific DNA sequences belonging to B.
Primary cutaneous large B-celllymphomas of the legs: adistincttype of cutaneous B-cell lymphoma with an intermediate prognosis; Dutch Cutaneous Lymphoma Working Group.
Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
T-cell lymphomas (6%), 2 lymphomatoid papulosis (6%), 1 Sezary syndrome (3%), and 1 subcutaneous panniculitislike T-cell lymphoma (3%); 8 cases (26%) were primary cutaneous B-cell lymphomas, including 3 primary cutaneous marginal zone B-cell lymphomas (10%), 3 primary cutaneous follicle center lymphomas (10%), and 2 primary cutaneous diffuse large B-cell lymphomas (6%), leg type.